Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-11-21
pubmed:abstractText
The peripheral blood lymphocytes of eight patients with metastatic renal cell carcinoma, and of eight healthy volunteers were analyzed by four-color flow cytometry to characterize the immunophenotypic alterations manifested, determine the prevalence of lymphocyte apoptosis, and detect evidence of the systemic effect of inhaled IL-2. The T, B and NK lymphocytes of untreated patients were found to have undergone profound changes characterized by an increase in susceptibility to both spontaneous and mitogen-induced ex vivo apoptosis, a modified distribution of the main lymphocyte populations in the peripheral blood, and alterations in activation status. An increase in the proportion of regulatory T cells was also seen in these patients. Treatment with inhaled IL-2, however, normalized the rate of apoptosis in all the lymphocyte subpopulations studied, as well as their distribution and activation status. These findings demonstrate that inhaled IL-2 has systemic immunomodulatory effects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1432-0851
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
235-45
pubmed:meshHeading
pubmed-meshheading:18592236-Adult, pubmed-meshheading:18592236-Aged, pubmed-meshheading:18592236-Antineoplastic Agents, pubmed-meshheading:18592236-B-Lymphocytes, pubmed-meshheading:18592236-Carcinoma, Renal Cell, pubmed-meshheading:18592236-Cell Proliferation, pubmed-meshheading:18592236-Cells, Cultured, pubmed-meshheading:18592236-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18592236-Female, pubmed-meshheading:18592236-Humans, pubmed-meshheading:18592236-Immunoglobulins, Intravenous, pubmed-meshheading:18592236-Immunologic Factors, pubmed-meshheading:18592236-Inhalation, pubmed-meshheading:18592236-Interleukin-2, pubmed-meshheading:18592236-Kidney Neoplasms, pubmed-meshheading:18592236-Killer Cells, Natural, pubmed-meshheading:18592236-Lung Neoplasms, pubmed-meshheading:18592236-Lymphocyte Activation, pubmed-meshheading:18592236-Male, pubmed-meshheading:18592236-Middle Aged, pubmed-meshheading:18592236-T-Lymphocytes
pubmed:year
2009
pubmed:articleTitle
Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis.
pubmed:affiliation
CNB-CSIC R&D Associated Unit, Department of Medicine, University of Alcalá, Madrid, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't